SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043377
Filing Date
2018-08-09
Accepted
2018-08-09 17:16:45
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499859_10q.htm 10-Q 307269
2 EXHIBIT 31.1 tv499859_ex31-1.htm EX-31.1 11443
3 EXHIBIT 31.2 tv499859_ex31-2.htm EX-31.2 11512
4 EXHIBIT 32.1 tv499859_ex32-1.htm EX-32.1 3880
5 EXHIBIT 32.2 tv499859_ex32-2.htm EX-32.2 4196
  Complete submission text file 0001144204-18-043377.txt   2105158

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20180630.xml EX-101.INS 302709
7 XBRL TAXONOMY EXTENSION SCHEMA cycc-20180630.xsd EX-101.SCH 26742
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycc-20180630_cal.xml EX-101.CAL 25969
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20180630_def.xml EX-101.DEF 94458
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20180630_lab.xml EX-101.LAB 257477
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20180630_pre.xml EX-101.PRE 165241
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 181006348
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences